Follow
Sigurdis Haraldsdottir
Sigurdis Haraldsdottir
Verified email at hi.is
Title
Cited by
Cited by
Year
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations
S Haraldsdottir, H Hampel, J Tomsic, WL Frankel, R Pearlman, ...
Gastroenterology 147 (6), 1308-1316. e1, 2014
3982014
NCCN guidelines insights: genetic/familial high-risk assessment: colorectal, version 2.2019: featured updates to the NCCN guidelines
S Gupta, D Provenzale, X Llor, AL Halverson, W Grady, DC Chung, ...
Journal of the National Comprehensive Cancer Network 17 (9), 1032-1041, 2019
2262019
Colorectal cancer-review
S Haraldsdottir, HM Einarsdottir, A Smaradottir, A Gunnlaugsson, ...
Laeknabladid 100 (2), 75-82, 2014
1702014
Comprehensive population-wide analysis of Lynch syndrome in Iceland reveals founder mutations in MSH6 and PMS2
S Haraldsdottir, T Rafnar, WL Frankel, S Einarsdottir, A Sigurdsson, ...
Nature communications 8 (1), 14755, 2017
1302017
Prostate cancer incidence in males with Lynch syndrome
S Haraldsdottir, H Hampel, L Wei, C Wu, W Frankel, T Bekaii-Saab, ...
Genetics in medicine 16 (7), 553-557, 2014
1272014
Anti-proliferative effects of lichen-derived lipoxygenase inhibitors on twelve human cancer cell lines of different tissue origin in vitro
S Haraldsdóttir, E Guðlaugsdóttir, K Ingólfsdóttir, HM Ögmundsdóttir
Planta medica 70 (11), 1098-1100, 2004
832004
Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome
R Pearlman, S Haraldsdottir, A De La Chapelle, JG Jonasson, ...
Journal of medical genetics 56 (7), 462-470, 2019
692019
Effects of tenuiorin and methyl orsellinate from the lichen Peltigera leucophlebia on 5-/15-lipoxygenases and proliferation of malignant cell lines in vitro
K Ingólfsdóttir, GF Gudmundsdóttir, HM Ögmundsdóttir, K Paulus, ...
Phytomedicine 9 (7), 654-658, 2002
552002
Management of borderline resectable pancreatic cancer
DAS Toesca, AJ Koong, GA Poultsides, BC Visser, S Haraldsdottir, ...
International Journal of Radiation Oncology* Biology* Physics 100 (5), 1155-1174, 2018
532018
Promising new agents for colorectal cancer
S Das, KK Ciombor, S Haraldsdottir, RM Goldberg
Current treatment options in oncology 19, 1-14, 2018
502018
Patients with colorectal cancer associated with Lynch syndrome and MLH1 promoter hypermethylation have similar prognoses
S Haraldsdottir, H Hampel, C Wu, DY Weng, PG Shields, WL Frankel, ...
Genetics in medicine 18 (9), 863-868, 2016
452016
Mismatch repair deficiency concordance between primary colorectal cancer and corresponding metastasis
S Haraldsdottir, R Roth, R Pearlman, H Hampel, CA Arnold, WL Frankel
Familial Cancer 15, 253-260, 2016
442016
Diagnostic accuracy of 64-slice multidetector CT for detection of in-stent restenosis in an unselected, consecutive patient population
S Haraldsdottir, T Gudnason, AF Sigurdsson, J Gudjonsdottir, SJ Lehman, ...
European journal of radiology 76 (2), 188-194, 2010
432010
Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine/nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.
N Bahary, A Wang-Gillam, S Haraldsdottir, BG Somer, JS Lee, ...
Journal of Clinical Oncology 36 (15_suppl), 4015-4015, 2018
412018
Frequent PIK3CA mutations in colorectal and endometrial tumors with 2 or more somatic mutations in mismatch repair genes
SA Cohen, EH Turner, MB Beightol, A Jacobson, TA Gooley, SJ Salipante, ...
Gastroenterology 151 (3), 440-447. e1, 2016
402016
An update on clinical trials of targeted therapies in thyroid cancer
S Haraldsdottir, MH Shah
Oncology in Clinical Practice 10 (2), 121-130, 2014
402014
Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome
JA Hemminger, R Pearlman, S Haraldsdottir, D Knight, JG Jonasson, ...
Human pathology 78, 125-130, 2018
352018
Integrating anti-EGFR therapies in metastatic colorectal cancer
S Haraldsdottir, T Bekaii-Saab
Journal of gastrointestinal oncology 4 (3), 285, 2013
342013
Microsatellite instability and adjuvant chemotherapy in stage II colon cancer
JL Koenig, DAS Toesca, JP Harris, CJ Tsai, S Haraldsdottir, AY Lin, ...
American Journal of Clinical Oncology 42 (7), 573-580, 2019
312019
Targeting BRAF mutations in high-grade neuroendocrine carcinoma of the colon
J Burkart, D Owen, MH Shah, SRZ Abdel-Misih, S Roychowdhury, ...
Journal of the National Comprehensive Cancer Network 16 (9), 1035-1040, 2018
312018
The system can't perform the operation now. Try again later.
Articles 1–20